These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32781293)

  • 1. Higher intestinal and circulatory lactate associated NOX2 activation leads to an ectopic fibrotic pathology following microcystin co-exposure in murine fatty liver disease.
    Sarkar S; Saha P; Seth RK; Mondal A; Bose D; Kimono D; Albadrani M; Mukherjee A; Porter DE; Scott GI; Xiao S; Brooks B; Ferry J; Nagarkatti M; Nagarkatti P; Chatterjee S
    Comp Biochem Physiol C Toxicol Pharmacol; 2020 Dec; 238():108854. PubMed ID: 32781293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21.
    Albadrani M; Seth RK; Sarkar S; Kimono D; Mondal A; Bose D; Porter DE; Scott GI; Brooks B; Raychoudhury S; Nagarkatti M; Nagarkatti P; Jule Y; Diehl AM; Chatterjee S
    Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G408-G428. PubMed ID: 31393787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental microcystin targets the microbiome and increases the risk of intestinal inflammatory pathology via NOX2 in underlying murine model of Nonalcoholic Fatty Liver Disease.
    Sarkar S; Kimono D; Albadrani M; Seth RK; Busbee P; Alghetaa H; Porter DE; Scott GI; Brooks B; Nagarkatti M; Nagarkatti P; Chatterjee S
    Sci Rep; 2019 Jun; 9(1):8742. PubMed ID: 31217465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microcystin exposure worsens nonalcoholic fatty liver disease associated ectopic glomerular toxicity via NOX-2-MIR21 axis.
    Sarkar S; Alhasson F; Kimono D; Albadrani M; Seth RK; Xiao S; Porter DE; Scott GI; Brooks B; Nagarkatti M; Nagarkatti P; Chatterjee S
    Environ Toxicol Pharmacol; 2020 Jan; 73():103281. PubMed ID: 31706246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.
    Chandrashekaran V; Seth RK; Dattaroy D; Alhasson F; Ziolenka J; Carson J; Berger FG; Kalyanaraman B; Diehl AM; Chatterjee S
    Redox Biol; 2017 Oct; 13():8-19. PubMed ID: 28551086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High circulatory leptin mediated NOX-2-peroxynitrite-miR21 axis activate mesangial cells and promotes renal inflammatory pathology in nonalcoholic fatty liver disease.
    Alhasson F; Seth RK; Sarkar S; Kimono DA; Albadrani MS; Dattaroy D; Chandrashekaran V; Scott GI; Raychoudhury S; Nagarkatti M; Nagarkatti P; Diehl AM; Chatterjee S
    Redox Biol; 2018 Jul; 17():1-15. PubMed ID: 29660503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental Microcystin exposure in underlying NAFLD-induced exacerbation of neuroinflammation, blood-brain barrier dysfunction, and neurodegeneration are NLRP3 and S100B dependent.
    Mondal A; Saha P; Bose D; Chatterjee S; Seth RK; Xiao S; Porter DE; Brooks BW; Scott GI; Nagarkatti M; Nagarkatti P; Chatterjee S
    Toxicology; 2021 Sep; 461():152901. PubMed ID: 34416350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Low Dose Oral Exposure to Microcystin-LR Exacerbates Hepatic Injury in a Murine Model of Non-Alcoholic Fatty Liver Disease.
    Lad A; Su RC; Breidenbach JD; Stemmer PM; Carruthers NJ; Sanchez NK; Khalaf FK; Zhang S; Kleinhenz AL; Dube P; Mohammed CJ; Westrick JA; Crawford EL; Palagama D; Baliu-Rodriguez D; Isailovic D; Levison B; Modyanov N; Gohara AF; Malhotra D; Haller ST; Kennedy DJ
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31450746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does Nox2 Overactivate in Children with Nonalcoholic Fatty Liver Disease?
    Loffredo L; Zicari AM; Perri L; Carnevale R; Nocella C; Angelico F; Del Ben M; Mosca A; Zaffina S; Panera N; Alisi A; Duse M; Violi F; Nobili V
    Antioxid Redox Signal; 2019 Apr; 30(10):1325-1330. PubMed ID: 30019598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early microcystin-LR exposure-linked inflammasome activation in mice causes development of fatty liver disease and insulin resistance.
    Al-Badrani M; Saha P; Mondal A; Seth RK; Sarkar S; Kimono D; Bose D; Porter DE; Scott GI; Brooks B; Raychoudhury S; Nagarkatti M; Nagarkatti P; Chatterjee S
    Environ Toxicol Pharmacol; 2020 Nov; 80():103457. PubMed ID: 32687983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcystin-leucine arginine exposure induced intestinal lipid accumulation and MC-LR efflux disorder in Lithobates catesbeianus tadpoles.
    He J; Shu Y; Dai Y; Gao Y; Liu S; Wang W; Jiang H; Zhang H; Hong P; Wu H
    Toxicology; 2022 Jan; 465():153058. PubMed ID: 34863901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
    Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
    Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of in vitro effects of microcystin-LR on intestinal epithelial cells.
    Zhou Y; Xu X; Yu B; Yu G
    Environ Toxicol; 2017 May; 32(5):1539-1547. PubMed ID: 27758031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative impacts of microcystin-LR and glyphosate on zebrafish intestine: Linked with gut microbiota and microRNAs?
    Ding W; Shangguan Y; Zhu Y; Sultan Y; Feng Y; Zhang B; Liu Y; Ma J; Li X
    Environ Pollut; 2021 Oct; 286():117685. PubMed ID: 34438504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical response of diverse organs in adult Danio rerio (zebrafish) exposed to sub-lethal concentrations of microcystin-LR and microcystin-RR: a balneation study.
    Pavagadhi S; Gong Z; Hande MP; Dionysiou DD; de la Cruz AA; Balasubramanian R
    Aquat Toxicol; 2012 Mar; 109():1-10. PubMed ID: 22207040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcystin-LR promotes cell proliferation in the mice liver by activating Akt and p38/ERK/JNK cascades.
    Liu J; Wang B; Huang P; Wang H; Xu K; Wang X; Xu L; Guo Z
    Chemosphere; 2016 Nov; 163():14-21. PubMed ID: 27517128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic and intestine alterations in mice after prolonged exposure to low oral doses of Microcystin-LR.
    Sedan D; Laguens M; Copparoni G; Aranda JO; Giannuzzi L; Marra CA; Andrinolo D
    Toxicon; 2015 Sep; 104():26-33. PubMed ID: 26210502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term environmental exposure to microcystins increases the risk of nonalcoholic fatty liver disease in humans: A combined fisher-based investigation and murine model study.
    Zhao Y; Yan Y; Xie L; Wang L; He Y; Wan X; Xue Q
    Environ Int; 2020 May; 138():105648. PubMed ID: 32187572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyanotoxins Increase Cytotoxicity and Promote Nonalcoholic Fatty Liver Disease Progression by Enhancing Cell Steatosis.
    Niture S; Gadi S; Qi Q; Rios-Colon L; Khatiwada S; Vandana ; Fernando RA; Levine KE; Kumar D
    Toxins (Basel); 2023 Jun; 15(7):. PubMed ID: 37505679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis.
    Dattaroy D; Pourhoseini S; Das S; Alhasson F; Seth RK; Nagarkatti M; Michelotti GA; Diehl AM; Chatterjee S
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G298-312. PubMed ID: 25501551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.